Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature.

Silvia Bloise Alessia Marcellino Vanessa Martucci Mariateresa SansevieroAlessia TestaEmanuela Del GiudiceMattia SpatuzzoDaniel SermonetaFlavia VentrigliaRiccardo Lubrano

Published in: Children (Basel, Switzerland) (2022)

At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine.

Keyphrases

sars cov
young adults
coronavirus disease
respiratory syndrome coronavirus
physical activity
artificial intelligence